Correspondence to Dr Ailsa Hart, IBD Unit, St Mark's Hospital and Imperial College London ... and gives an insight into how this might impact on clinical practice. The evidence for the preventive and ...
Fact checked by Nick Blackmer The recent approvals of Leqembi (lecanemab) and Kisunla (donanemab) have refreshed the landscape of Alzheimer’s disease treatments. For the first time, patients have the ...